3 Promising Gene Therapy Stocks
Article By:
Tarun Chandra, CFA
Read
Saturday, May 25, 2019 9:45 PM EDT
Investor interest in gene therapy companies has been on the rise. Here is a look at 3 promising small cap gene therapy companies.
In this article: BOLD, VYGR, QURE Also: SRPT, PTCT, BLUE, ONCE, EDIT, NTLA, CRSP, RGNX, SLDB, FIXX, MGTX, NVS, RHHBY, GOOG, ACAD, ARNA, ARRY, CBPO, PCRX, AMRN, SAGE, MRNA, GWPH, ASND, RARX, BHVN, MRTX, DNLI, CHRS, MDCO, ARWR, ZIOP, TGTX, PTLA, GBT, AXSM
Week In Review: WuXi Biologics Signs LOI For $3 Billion Vaccine Contract
Article By:
ChinaBio® Today
Read
Saturday, May 25, 2019 4:09 PM EDT
WuXi Biologics signed a partnership LOI with an unnamed vaccine company to supply $3 billion of vaccines over 20 years and build a dedicated manufacturing facility
Is AbbVie Stock A Buy In May 2019?
Article By:
SureDividend
Read
Saturday, May 25, 2019 2:00 PM EDT
Volatility has returned to the stock market, as a result of escalating trade tensions. During periods of heightened geopolitical risk, it is a good time for investors to refocus on high-quality dividend growth stocks.
E Research Report: PBYI
Article By:
Elle Investments
Read
Friday, May 24, 2019 1:41 PM EDT
The lowered 2019 Nerlynx net sales guidance after 1Q19 results puts previous peak sales estimates of $1B+ in doubt. However, given the large sell-off, even with much lower peak sales estimates in the $500M+ range, there is still a lot of upside.
In this article: PBYI
Week In Review: MGI Tech Raises $200 Million To Manufacture Genomic Sequencing Machines
Article By:
ChinaBio® Today
Read
Saturday, May 18, 2019 10:23 PM EDT
MGI Tech a Shenzhen maker of gene sequencing machines and a subsidiary of genomics company BGI, completed an A funding of more than $200 million.
It's Still Not Too Late To Get On Board Of The BioLife Solutions Train
Article By:
Shareholders Unite
Read
Friday, May 17, 2019 10:58 AM EDT
BLFS) is a stock to benefit from the early innings of regenerative medicine revolution with multiple avenues for growth ahead if it.BLFS
In this article: BLFS
AskSlim Market Week - Saturday, May 11
Video By:
Steve Miller
Watch
Saturday, May 11, 2019 4:31 PM EDT
The stock market dropped sharply lower this week, the worst week for the stock market in 2019, as tensions increased on the US-China trade war along with other geopolitical concerns.
Week In Review: Gene Editing Scandal; Can China Biopharma Continue To Expand? News On Three China Life Science IPOs
Article By:
ChinaBio® Today
Read
Saturday, May 11, 2019 4:11 PM EDT
Regulatory changes are speeding drug development timelines for novel imported drugs in China, and VCs raised over $40 billion in new funding last year. Was 2018 as good as it gets, or can the growth in investment activity continue?
Week In Review: Everest In-Licenses An ADC From Immunomedics In $835 Million Agreement, A China Record For A Single Asset
Article By:
ChinaBio® Today
Read
Saturday, May 4, 2019 5:44 PM EDT
Everest Medicines II of Shanghai, a C-Bridge company, agreed to pay up to a record $835 million in upfront and milestone payments for China rights to an Immunomedics ADC.
E Finally A Real Cancer Diagnosis Breakthrough?
Article By:
Terry Chrisomalis
Read
Friday, May 3, 2019 8:04 AM EDT
TOMDF is a diagnostics company that utilizes blood tests for early detection of cancer and neurodegenerative diseases. But is it a good investment? I took a deeper look and reached out to the company's CEO, Herman Weiss, to get the facts.
In "Stunning Decision" Bayer Shareholders Dump CEO Over Disastrous Monsanto Purchase
Article By:
Tyler Durden
Read
Sunday, April 28, 2019 12:24 PM EDT
Bayer survived World War II but it may not survive the worst acquisition in its history: the disastrous $63 billion purchase of Monsanto in 2018, which also brought the carcinogenic weed-killer Roundup and countless lawsuits and legal charges.
In this article: BAYRY